Tól
Sigur kontinuerlig blóðsykurmonitorar fr healthy fólk?
CGM er umskiftandi í diabetes. Hjá fólki uttan tað, mæla tey mest ting, hvøtt týdningurin ikki er staðfestur.
Hvat ein CGM mælir
Ein filament í interstitial vøtt, teknað hvønn minutt, umbrotið til ein mettur blóðsukur. Tvær avleiðingar fylgja. Tað liggur eftir blóðsukrinum í fleiri minutt, sum er týdningarmikið tá vit talar um skjótt broytingar. Og tað er kalibrerað fyri diabetes-økið, har nákvæmniskravini eru ymisk frá at loysa smáar broytingar í einum, har blóðsukur aldrei fer út av normalbandinum.
Hvat er væl staðfest
Í diabetes, málið er klart. Hybrid lukka-loppskipanir betraðu bæði glykemisk og psychosocial úrslit í randomiserðum royndum [7], og CGM er brúkt til at samanbera lykniefter á breytni beint — empagliflozin móti metformin, til dømis [2]. Mesenchymale stamfrøði royndir í diabetes hava brúkt tað sum ein endapunkt [5]. Hetta eru tær umsóknir, sum teknologian var bygdur fyri.
CGM í diabetes
Hvat er ikki staðfest hjá fólki uttan diabetes
Triðja kravini verða gjørd regluliga og ongin hevur royndarstøtt:
- At toppar í einum ikki-diabetiskum øki eru skaðilig. Postprandial blóðsukur hækkar eftir at eta. Tað er systemið, sum arbeiðir. Ongin roynd hevur víst, at ein normal-øki útreiðing orsakast skaða.
- At at flata kurvuna betrar heilsuúrslit. Ongin randomiserð roynd hjá fólki uttan diabetes hevur víst fyrimun á nakað harða endapunkt frá at minka breytni.
- At tín persónliga svar vísir mat, sum er ringt fyri teg. Svar breytir seg við søvn, stress, fyrra máltíðir, venjing, sensor staðseting og sensorin sjálvur. Tvær sensorar, sum eru bornir samstundis, eru ofta ósamdir á ein hátt.
Hvat genuint broytir kurvuna
Nokkur funn eru solid og áhugaverd. Ein lágt kolhydratar morgunmat framleiðir ein lægri postprandial svar enn ein lágt feitt [4] — óvanligt men væl staðfest. Ein høgt protein morgunmat broytir postprandial profilin [6]. DASH4D royndin granskaði diatákn á glykemisk kontrol og breytni á ein struktureran hátt [3].
Tað mest óvæntað: ein randomiserð roynd fann, at náttúrligt dagsljós í arbeiðstíð betraði blóðsukurskontroll [1]. Ljóssamband er ein circadian breytni, ikki ein diat breytni, og tað vísir, hvussu nógv av blóðsukursregulering situr uttan tað, tú etti. Relaterað lesing á okkara sleep evidence site.
Nær ein CGM er genuint nyttugur uttan diabetes
- Prediabetes, har tú fylgir eini verulig kliniskari leið.
- Reaktiv hypoglykaemia symptom, har at samskipa symptom við verulig lesingar er diagnostiskt.
- Genuin nyfiring, heiðursfull, við realistiskum væntan um hvat ein fjórðing av data kann siga tær.
- Atferðar feedback, sum er tað mest forsvarligan brúki — nakrir fólk eta betur, tá nakað er at hyggja at, og tað er ein gyldig orsøkin, sjálvt um blóðsukursdata sjálvt er óinformativt.
Vanlig spurningar
Er ein blóðsukurtoppur eftir at eta ringur?
Skal eg eta fyri at halda mín linju flata?
Hví gav sama máltíð ymisk úrslit?
Kann ein CGM avdúka prediabetes?
Viðmerkingar
Hver einasta tilvísing niðanfyri bendir til upprunaliga peer-reviewed skjalið á PubMed ella gjøgnum DOI. Einki her er ein staðfesting fyri læknaligt ráð.
-
Effects of short-bout accumulated physical activity and sedentary-break interventions on continuous glucose monitoring metrics in adults with type 2 diabetes: A systematic review and meta-analysis Cao S, Wang H, Zhu Y, et al. · Frontiers in endocrinology · 2026 · Meta-analysis DOIPubMed 42798338Full text
-
Maternal high-protein/low-glycemic-index diet during pregnancy impairs offspring lipid profile-a randomized controlled trial Mogensen CS, Magkos F, Chabanova E, et al. · European journal of nutrition · 2026 · Randomised controlled trial DOIPubMed 42417833Full text
-
Natural daylight during office hours improves glucose control and whole-body substrate metabolism Harmsen JF, Habets I, Biancolin AD, et al. · Cell metabolism · 2026 · Randomised controlled trial DOIPubMed 41418772
-
Empagliflozin versus metformin for glucose variability and metabolic outcomes in drug-naïve type 2 diabetes: The EMPA-FIT study Lim S, Park CY, Jeong IK, et al. · Journal of diabetes and its complications · 2026 · Randomised controlled trial DOIPubMed 41223492
-
Interaction of melatonin receptor 1B (MTNR1B) genotype and type of breakfast (protein-enriched v carbohydrate-rich) on postprandial glucose response: a randomised crossover trial King A, Nixon J, Kapellou A, et al. · European journal of clinical nutrition · 2026 · Randomised controlled trial DOIPubMed 42521769
-
Effect of a Personalized Mobile App on Glucose Control in Adults With Prediabetes and Type 2 Diabetes: Exploratory Pilot Randomized Controlled Trial Lalama E, Csanalosi M, Kabisch S, et al. · JMIR human factors · 2026 · Randomised controlled trial DOIPubMed 42342244Full text
-
Sleep Optimization to Improve Glycemic Targets in Adults With Type 1 Diabetes: A Randomized Controlled Parallel Intervention Trial Martyn-Nemeth P, Duffecy J, Steffen AD, et al. · Diabetes care · 2026 · Randomised controlled trial DOIPubMed 42149583Full text
-
Relationship Between Sleep and Meal Timing with Glycemia Parameters in Individuals with Obesity Participating in a Randomized Time-Restricted Eating Study Reutrakul S, Simon SL, Wang Q, et al. · Nutrients · 2026 · Randomised controlled trial DOIPubMed 42280467Full text
-
Understanding the Metabolic and Endocrine Effects of Macronutrient Boluses in the Context of a Low-Carbohydrate Diet: A Randomized Crossover Study Deru LS, Bailey BW, Hales KE, et al. · Nutrients · 2026 · Randomised controlled trial DOIPubMed 42654249Full text
-
DASH4D diet for glycemic control and glucose variability in type 2 diabetes: a randomized crossover trial Fang M, Wang D, Rebholz CM, et al. · Nature medicine · 2025 · Randomised controlled trial DOIPubMed 40764427Full text
-
In-Hospital Diabetes Management by a Diabetes Team and Insulin Titration Algorithms Based on Continuous Glucose Monitoring or Point-of-Care Glucose Testing in Patients With Type 2 Diabetes (DIATEC): A Randomized Controlled Trial Olsen MT, Klarskov CK, Jensen SH, et al. · Diabetes care · 2025 · Randomised controlled trial DOIPubMed 39887698
-
Use of real-time continuous glucose monitoring in non-critical care insulin-treated inpatients under non-diabetes speciality teams in hospital: A pilot randomized controlled study Thabit H, Rubio J, Karuppan M, et al. · Diabetes, obesity & metabolism · 2024 · Randomised controlled trial DOIPubMed 39169520
-
Continuous Glucose Monitoring Profiles and Health Outcomes After Dapagliflozin Plus Saxagliptin vs Insulin Glargine Simonson DC, Testa MA, Ekholm E, et al. · The Journal of clinical endocrinology and metabolism · 2024 · Randomised controlled trial DOIPubMed 38412282
-
Impact of a Low-Carbohydrate Compared with Low-Fat Breakfast on Blood Glucose Control in Type 2 Diabetes: A Randomized Trial Oliveira BF, Chang CR, Oetsch K, et al. · The American journal of clinical nutrition · 2023 · Randomised controlled trial DOIPubMed 37257563
-
Efficacy of Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Type 2 Diabetes Assessed by Retrospective Continuous Glucose Monitoring Zang L, Li Y, Hao H, et al. · Stem cells translational medicine · 2023 · Randomised controlled trial DOIPubMed 37738447Full text
-
Effect of a High Protein Diet at Breakfast on Postprandial Glucose Level at Dinner Time in Healthy Adults Xiao K, Furutani A, Sasaki H, et al. · Nutrients · 2022 · Randomised controlled trial DOIPubMed 36615743Full text
-
Effect of a Hybrid Closed-Loop System on Glycemic and Psychosocial Outcomes in Children and Adolescents With Type 1 Diabetes: A Randomized Clinical Trial Abraham MB, de Bock M, Smith GJ, et al. · JAMA pediatrics · 2021 · Randomised controlled trial DOIPubMed 34633418Full text
-
Improved Glycemic Control and Variability: Application of Healthy Ingredients in Asian Staples Camps SG, Kaur B, Lim J, et al. · Nutrients · 2021 · Randomised controlled trial DOIPubMed 34578981Full text
-
Continuous Glucose Monitoring in Very Preterm Infants: A Randomized Controlled Trial Galderisi A, Facchinetti A, Steil GM, et al. · Pediatrics · 2017 · Randomised controlled trial DOIPubMed 28916591
-
Comparison of low- and high-carbohydrate diets for type 2 diabetes management: a randomized trial Tay J, Luscombe-Marsh ND, Thompson CH, et al. · The American journal of clinical nutrition · 2015 · Randomised controlled trial DOIPubMed 26224300
-
Continuous Glucose Monitoring for Prediabetes: What Are the Best Metrics? Zahalka SJ, Galindo RJ, Shah VN, et al. · Journal of diabetes science and technology · 2024 · Review DOIPubMed 38629784Full text
-
Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring Yapanis M, James S, Craig ME, et al. · The Journal of clinical endocrinology and metabolism · 2022 · Review DOIPubMed 35094087Full text
-
Continuous Glucose Monitoring and Physical Activity Schubert-Olesen O, Kröger J, Siegmund T, et al. · International journal of environmental research and public health · 2022 · Review DOIPubMed 36231598Full text
-
Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study Shah VN, DuBose SN, Li Z, et al. · The Journal of clinical endocrinology and metabolism · 2019 · Journal article DOIPubMed 31127824Full text